RadNet to Host Free Men’s Health Webinar Focused on Early Detection of Heart Disease, Prostate Cancer, and Lung Cancer
RadNet,a leading provider of outpatient diagnostic imaging services and radiology technology solutions in the United States, has announced a free educational webinar dedicated to raising awareness about men’s health and the importance of early disease detection. Scheduled for Saturday, June 13, 2026, the event is being held in recognition of National Men’s Health Month and will feature expert physicians discussing some of the most significant health challenges affecting men today.
The virtual event is designed to provide patients, caregivers, and members of the public with valuable information about coronary artery disease, prostate cancer, and lung cancer—three conditions that continue to have a major impact on men’s health across the country. Through expert-led presentations and an interactive question-and-answer session, attendees will gain insight into risk factors, screening recommendations, and the role advanced imaging technologies play in detecting disease at earlier and more treatable stages.
Addressing Critical Men’s Health Challenges
Men continue to face elevated risks from several chronic and life-threatening diseases, many of which can progress silently before symptoms become apparent. Healthcare professionals emphasize that routine screening and early detection are among the most effective strategies for reducing mortality and improving long-term outcomes.
Heart disease remains the leading cause of death among American men. According to current health data, more than half of men over the age of 20 are living with some form of cardiovascular disease. Conditions such as coronary artery disease often develop gradually over time, with plaque buildup narrowing arteries and increasing the risk of heart attacks and other serious cardiovascular events. Because symptoms may not appear until the disease is advanced, preventive screening and risk assessment are becoming increasingly important components of cardiovascular care.
Prostate cancer is another major health concern affecting men worldwide. It is the second most commonly diagnosed cancer among men and impacts approximately one in eight men during their lifetime. Genetics play a substantial role in determining risk, with family history accounting for a significant percentage of cases. Advances in diagnostic imaging and artificial intelligence are helping physicians identify potentially aggressive cancers earlier, enabling more personalized treatment planning and improved patient outcomes.
Lung cancer continues to be the leading cause of cancer-related deaths among men. Despite advances in treatment, many cases are still diagnosed at later stages when treatment options may be more limited. Experts note that low-dose CT screening has become an important tool for identifying lung cancer in high-risk individuals before symptoms develop. Early-stage detection can dramatically improve survival rates and increase the range of available treatment options.
Recognizing the importance of education and awareness, RadNet has organized this webinar to help individuals better understand these conditions and learn about available screening technologies that may support earlier diagnosis.
Expert-Led Presentations
The June 13 webinar will feature presentations from experienced radiologists and medical directors within RadNet’s network. Each speaker will focus on a specific health condition and discuss how imaging technologies are transforming early detection and disease management.
Coronary Artery Disease and Cardiac Imaging
Dr. Michael G. Coords, Medical Director for California and a specialist in cardiovascular imaging, will provide an overview of coronary artery disease. His presentation will explore common risk factors, including age, family history, smoking, high cholesterol, hypertension, diabetes, and lifestyle-related factors.
Dr. Coords will also discuss how advanced imaging tools, including cardiac CT technology, can help physicians identify early signs of disease before a major cardiac event occurs. By detecting plaque buildup and assessing cardiovascular risk earlier, healthcare providers can work with patients to develop preventive strategies and treatment plans aimed at reducing future complications.
Advances in Prostate Cancer Detection
Dr. Randall Stenoien, Medical Director for Texas, will present on the evolving role of prostate MRI and artificial intelligence in prostate cancer screening and diagnosis.
In recent years, multiparametric MRI has become an increasingly valuable tool for evaluating the prostate and identifying suspicious lesions that may require further investigation. Combined with AI-powered image analysis, these technologies are helping radiologists improve diagnostic accuracy while reducing unnecessary procedures.
Dr. Stenoien will discuss how these innovations are supporting earlier detection, improving patient care, and helping physicians make more informed decisions regarding treatment and monitoring strategies.
Lung Cancer Screening and Low-Dose CT
Dr. Evan Kaminer, Medical Director for New York, will focus on lung cancer screening and the benefits of low-dose computed tomography (CT) for individuals considered at high risk for the disease.
Low-dose CT screening has emerged as a highly effective method for identifying lung abnormalities before symptoms appear. During the webinar, Dr. Kaminer will explain eligibility criteria, screening recommendations, and the clinical evidence supporting the use of low-dose CT scans as a life-saving preventive measure.
His presentation will highlight how early detection can lead to better treatment outcomes and improved survival rates for patients diagnosed with lung cancer.
The Importance of Early Detection
A central theme of the webinar will be the critical role that early detection plays in improving patient outcomes across all three featured conditions.
Medical experts increasingly recommend that men discuss screening options with their healthcare providers based on age, family history, and individual risk factors. Current guidance suggests that conversations regarding heart disease screening may begin around age 40, while prostate cancer screening discussions often start around age 45. For lung cancer, screening may be recommended beginning around age 50 for individuals who meet specific risk criteria.
Advances in diagnostic imaging have made it possible to detect many diseases at earlier stages than ever before. Early diagnosis often enables less invasive treatment options, improves survival rates, and can significantly reduce healthcare costs associated with advanced disease management.
By educating the public about these opportunities, RadNet hopes to encourage more proactive engagement in preventive healthcare and promote informed decision-making among patients.
Expanding Access to Advanced Imaging
As one of the nation’s largest providers of outpatient diagnostic imaging services, RadNet continues to invest in technologies designed to improve patient access and diagnostic accuracy.
The company operates more than 435 outpatient imaging centers across 11 states, offering a broad range of imaging services including cardiac CT scans, prostate MRI examinations, and low-dose lung CT screening. These facilities are designed to provide convenient access to advanced diagnostic tools in community-based settings.
In addition to its imaging network, RadNet has expanded its capabilities through the development of AI-enhanced imaging solutions under its DeepHealth brand. These technologies support radiologists by improving workflow efficiency, assisting with image interpretation, and helping identify findings that may warrant further clinical attention.
By combining advanced technology with the expertise of highly trained radiologists, RadNet aims to deliver accurate and timely diagnostic information that supports physicians and patients throughout the healthcare journey.
Encouraging Conversations About Men’s Health
According to healthcare professionals, men are often less likely than women to seek preventive care or discuss health concerns with medical providers. This can contribute to delayed diagnoses and reduced opportunities for early intervention.
RadNet leaders believe educational initiatives such as the upcoming webinar can help bridge this gap by providing accessible information and encouraging open conversations about health risks, screening options, and preventive care.
“Men’s health is one of the most underrecognized areas of preventive healthcare,” said Gregory Sorensen, MD, Executive Vice President and Chief Strategy Officer at RadNet. “Providing people with access to reliable medical information and expert guidance empowers them to take a more proactive role in managing their health. Early detection remains one of the most powerful tools available for improving outcomes and saving lives.”
Event Information
The webinar is free and open to all members of the public.
Date: Saturday, June 13, 2026
Time: 10:00 a.m. – 11:00 a.m. PDT / 1:00 p.m. – 2:00 p.m. EDT
Participants will have the opportunity to hear directly from medical experts, learn about current screening recommendations, and ask questions during a live discussion session.
Through this educational initiative, RadNet aims to increase awareness of preventable and treatable diseases affecting men while highlighting the growing role of advanced imaging technologies in supporting earlier diagnosis, more effective treatment, and better overall health outcomes.
About RadNet, Inc.
RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of owned and/or operated outpatient imaging centers. RadNet’s imaging center markets include Arizona, California, Delaware, Florida, Idaho, Indiana, Maryland, New Jersey, New York, Texas and Virginia. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry globally. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has over 11,000 team members
